Breaking News
5 hours ago
Pharma Now Editorial Team

Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Lupin secures NMPA approval for Oseltamivir oral suspension in China through a co-development partnership with Yabao Pharmaceuticals.
Pharma Now Editorial Team

Venus Remedies secures SFDA approval for Plerixafor, marking entry into GCC specialty oncology injectables and raising the bar on site qualification strategy.
Pharma Now Editorial Team

FDA approves Differin Epiduo for OTC use under NDA 220736, triggering labeling, validation, and packaging compliance obligations for manufacturers.
Pharma Now Editorial Team

CHMP issues positive opinion for Boehringer Ingelheim's nerandomilast in IPF and PPF, advancing EU approval for the first new fibrosis therapy in over a decade.
Pharma Now Editorial Team
